Goal 3: Advance Translational Research

What is the best time to undergo a stem cell transplant (HCT)?

In this era of all the new therapies in cancer treatment, I believe stem cell transplants run the risk to be delegated to be used as last ditch effort to treat patients when all other therapy fails. Historically this has not been the group that benefitted the most from a transplant. I believe that better national studies need to be designed and funded to address the optimal use of transplant to benefit our patients including randomized trials comparing optimal non- TX therapy with upfront and delayed TXs. In addition economic impact of the different approaches on society need to be studied especially as many of the non -TX therapy approaches are also very expensive.

Tags (Keywords associated with the idea)


47 net votes
78 up votes
31 down votes
Idea No. 563